Physician profile

Paige M Gault

Endocrinology, Diabetes & Metabolism · Spartanburg, SC

NPI 1538185806

$1,506.37

in general payments reported to CMS, 2019-2025

18 companies · $526 in 2025

The $526 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

See the full distribution for Endocrinology, Diabetes & Metabolism

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,085.07

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $807.10 2019-2025 Freestyle Libre 3, Freestyle Libre
Lilly USA, LLC $209.93 2020-2025 Mounjaro
Dexcom, INC. $80.45 2019-2022
Amgen INC. $67.24 2019-2025 Evenity, Tepezza
Shire North American Group INC $49.30 2019
Novo Nordisk INC $49.24 2019-2024 Ozempic, Rybelsus
Sequel Med Tech, LLC $39.65 2025 Twiist
Astellas Pharma US INC $30.09 2023-2024 Veozah
Xeris Pharmaceuticals, INC. $26.37 2021-2022
Tandem Diabetes Care, INC. $24.82 2020
Intuity Medical INC $21.23 2023 Pogo Automatic Blood Glucose Monitoring System
Insulet Corporation $18.64 2022
Bayer Healthcare Pharmaceuticals INC. $17.00 2021
Amneal Pharmaceuticals LLC $16.72 2021
Recordati_rare_diseases_inc. $14.65 2021
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Bard Peripheral Vascular, INC. $11.83 2022
Medtronic Minimed, INC. $11.31 2019
Janssen Pharmaceuticals, INC $10.80 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Paige M Gault

$1,506.37

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $526 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

https://glasscript.com/doctor/69709/paige-m-gault

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.